These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

774 related articles for article (PubMed ID: 34445193)

  • 1. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis.
    Wang H; Tian T; Zhang J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell-derived SPON2 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by activating PYK2 in CRC.
    Huang C; Ou R; Chen X; Zhang Y; Li J; Liang Y; Zhu X; Liu L; Li M; Lin D; Qiu J; Liu G; Zhang L; Wu Y; Tang H; Liu Y; Liang L; Ding Y; Liao W
    J Exp Clin Cancer Res; 2021 Sep; 40(1):304. PubMed ID: 34583750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD133-containing microvesicles promote cancer progression by inducing M2-like tumor-associated macrophage polarization in the tumor microenvironment of colorectal cancer.
    Kim SY; Park S; Kim S; Ko J
    Carcinogenesis; 2024 May; 45(5):300-310. PubMed ID: 38085813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
    Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
    J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients.
    Tang J; Ming L; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Immunobiology; 2024 May; 229(3):152805. PubMed ID: 38669865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance.
    Mola S; Pandolfo C; Sica A; Porta C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gab2 promotes the growth of colorectal cancer by regulating the M2 polarization of tumor‑associated macrophages.
    Gao X; Long R; Qin M; Zhu W; Wei L; Dong P; Chen J; Luo J; Feng J
    Int J Mol Med; 2024 Jan; 53(1):. PubMed ID: 37937666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives.
    Hou S; Zhao Y; Chen J; Lin Y; Qi X
    J Transl Med; 2024 Jan; 22(1):62. PubMed ID: 38229160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tumor-associated macrophages at the invasive front in human colorectal cancer progression.
    Inagaki K; Kunisho S; Takigawa H; Yuge R; Oka S; Tanaka S; Shimamoto F; Chayama K; Kitadai Y
    Cancer Sci; 2021 Jul; 112(7):2692-2704. PubMed ID: 33964093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated macrophage-specific CD155 contributes to M2-phenotype transition, immunosuppression, and tumor progression in colorectal cancer.
    Zhu X; Liang R; Lan T; Ding D; Huang S; Shao J; Zheng Z; Chen T; Huang Y; Liu J; Pathak JL; Wei H; Wei B
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36104099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.
    Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N
    Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM198B promotes colorectal cancer progression by regulating the polarization of tumor-associated macrophages via the SMAD2 signaling pathway.
    Zheng X; Chen J; Nan T; Zheng L; Lan J; Jin X; Cai Y; Liu H; Chen W
    Bioengineered; 2022 May; 13(5):12435-12445. PubMed ID: 35587159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction with tumor‑associated macrophages promotes PRL‑3‑induced invasion of colorectal cancer cells via MAPK pathway‑induced EMT and NF‑κB signaling‑induced angiogenesis.
    Zhang T; Liu L; Lai W; Zeng Y; Xu H; Lan Q; Su P; Chu Z
    Oncol Rep; 2019 May; 41(5):2790-2802. PubMed ID: 30864736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ap-2α/Elk-1 axis regulates Sirpα-dependent tumor phagocytosis by tumor-associated macrophages in colorectal cancer.
    Wang X; Luo X; Chen C; Tang Y; Li L; Mo B; Liang H; Yu S
    Signal Transduct Target Ther; 2020 Apr; 5(1):35. PubMed ID: 32296015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic dysfunction and early-onset colorectal cancer - how macrophages build the bridge.
    Scheurlen KM; Billeter AT; O'Brien SJ; Galandiuk S
    Cancer Med; 2020 Sep; 9(18):6679-6693. PubMed ID: 33624450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling.
    Zhu Z; Hou Q; Guo H
    Exp Cell Res; 2020 Dec; 397(1):112311. PubMed ID: 32991874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTHRC1 promotes colorectal cancer progression by recruiting tumor-associated macrophages via up-regulation of CCL15.
    Liu Y; Chen X; Xu Y; Yang T; Wang H; Wang Z; Hu Z; Chen L; Zhang Z; Wu Y
    J Mol Med (Berl); 2024 Jan; 102(1):81-94. PubMed ID: 37987774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Associated Macrophages Promote Oxaliplatin Resistance
    Lan H; Liu Y; Liu J; Wang X; Guan Z; Du J; Jin K
    Mol Pharm; 2021 Mar; 18(3):1026-1037. PubMed ID: 33555197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.